Waander L. van Heerde

5.8k citations

102 papers · 3.6k indexed · h-index 32

Hematology top 0.5%
- Hemophilia Treatment and Research 38
- Platelet Disorders and Treatments 33
- Blood Coagulation and Thrombosis Mechanisms 28
Genetics top 2%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 15
Internal Medicine top 5%
Immunology top 5%
Molecular Biology top 5%
- S100 Proteins and Annexins 18
- Cell death mechanisms and regulation 8
Pulmonary and Respiratory Medicine
- Blood properties and coagulation 6
Surgery
- Heparin-Induced Thrombocytopenia and Thrombosis 6

Co-authors: Chris Reutelingsperger Philip G. de Groot Arnoud Loof Britta A. P. Laros‐van Gorkom Mark van Geffen Ebo DeMuinck Pieter A. Doevendans Leo Hofstra
Cited by: Hematology Genetics Internal Medicine
Journals: The Lancet (1 paper)Journal of Biological Chemistry (1 paper)Circulation (1 paper)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Waander L. van Heerde

97 papers receiving 3.6k citations

Peers

Countries citing papers authored by Waander L. van Heerde

Since Specialization

Citations

This map shows the geographic impact of Waander L. van Heerde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waander L. van Heerde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waander L. van Heerde more than expected).

Fields of papers citing papers by Waander L. van Heerde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waander L. van Heerde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waander L. van Heerde. The network helps show where Waander L. van Heerde may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Waander L. van Heerde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Waander L. van Heerde Line = papers co-authored together Waander L. van Heerde links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Health-related quality of life in rare bleeding disorders: results from the Rare Bleeding Disorders in the Netherlands study Research and Practice in Thrombosis and Haemostasis ·Sterre P E Willems,Marjon H. Cnossen,Nick van Es,Paul L. den Exter,Ilmar C. Kruis,Karina Meijer,Laurens Nieuwenhuizen,Joline L. Saes,Nicole M. A. Blijlevens,Waander L. van Heerde,Saskia E.M. Schols	2025	0
2	Novel microfluidic device for factor VIII quantification by chemiluminescence in hemophilia A patients Biosensors and Bioelectronics ·T J Steeghs,Lisa van Engelshoven,S P L Kuijpers,N M M Coolen,C. Ridder,Mark van Geffen,E. J. Lous,Saskia E.M. Schols,C Van't Veer,Waander L. van Heerde	2025	0
3	Bleeding symptoms in persons with rare bleeding disorders and a heterozygous genotype: data from the Rare Bleeding Disorders in the Netherlands study Journal of Thrombosis and Haemostasis ·Sara M. Willems,Marjon H. Cnossen,Nick van Es,Paul L. den Exter,Ilmar C. Kruis,Dominique P.M.S.M. Maas,Karina Meijer,Laurens Nieuwenhuizen,Sanna R. Rijpma,Joline L. Saes,Annet Simons,Roger Schutgens,Marjan M. Weiss,Nicole M. A. Blijlevens,Waander L. van Heerde,Saskia E.M. Schols	2025	1
4	Targeted exome analysis in patients with rare bleeding disorders: data from the Rare Bleeding Disorders in the Netherlands study Research and Practice in Thrombosis and Haemostasis ·Sterre P E Willems,Annet Simons,Joline L. Saes,Marjan M. Weiss,Sanna R. Rijpma,Selene Schoormans,Karina Meijer,Marjon H. Cnossen,Roger E. G. Schutgens,Nick van Es,Laurens Nieuwenhuizen,Paul L. den Exter,Ilmar C. Kruis,Nicole M. A. Blijlevens,Waander L. van Heerde,Saskia E.M. Schols	2024	4
5	Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study Journal of Thrombosis and Haemostasis ·Calvin B. van Kwawegen,Ferdows Atiq,Dara Endenburg,Karin Fijnvandraat,Karin P. M. van Galen,Marjon H. Cnossen,Saskia E.M. Schols,Marieke J. H. A. Kruip,Waander L. van Heerde,Joke de Meris,Johanna G. van der Bom,Jeroen Eikenboom,Karina Meijer,Frank W.G. Leebeek,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2024	2
6	In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype Research and Practice in Thrombosis and Haemostasis ·Marieke J.A. Verhagen,Waander L. van Heerde,Johanna G. van der Bom,Erik A.M. Beckers,Nicole M. A. Blijlevens,Michiel Coppens,Samantha C. Gouw,Joop H. Jansen,Frank W.G. Leebeek,Lize F. D. van Vulpen,Daniëlle Meijer,Saskia E.M. Schols	2023	12
7	PB0694 A Chemiluminescent-Based Multiparameter Platform for Simultaneous Measurement of Factor VIII Activity and Thrombin Generation Research and Practice in Thrombosis and Haemostasis ·Lisa van Engelshoven,D. Steeghs,N M M Coolen,S P L Kuijpers,Mark van Geffen,R. Vestering-Stenger,Cornelis van ′t Veer,Waander L. van Heerde	2023	0
8	Synthesis and Evaluation of Glycosyl Luciferins Chemistry - A European Journal ·Daan Sondag,Frank F. J. de Kleijne,Sam Castermans,Isa Chatzakis,Mark van Geffen,Cornelis van’t Veer,Waander L. van Heerde,Thomas J. Boltje,Floris P. J. T. Rutjes	2023	2
9	Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease Blood Advances ·Ferdows Atiq,Jessica M. Heijdra,Fleur Snijders,Johan Boender,Eva K Kempers,Waander L. van Heerde,Dominique P.M.S.M. Maas,Sandy Krouwel,Selene C. Schoormans,Joke de Meris,Saskia E.M. Schols,Karin P. M. van Galen,Johanna G. van der Bom,Marjon H. Cnossen,Karina Meijer,Karin Fijnvandraat,Jeroen Eikenboom,Frank W.G. Leebeek	2022	9
10	Von Willebrand disease type 2M: Correlation between genotype and phenotype Journal of Thrombosis and Haemostasis ·Dominique P.M.S.M. Maas,Ferdows Atiq,Nicole M. A. Blijlevens,Paul Brons,Sandy Krouwel,Britta A. P. Laros‐van Gorkom,Frank W.G. Leebeek,Laurens Nieuwenhuizen,Selene C. M. Schoormans,Annet Simons,Daniëlle Meijer,Waander L. van Heerde,Saskia E.M. Schols	2021	7
11	Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency Haemophilia ·Joline L. Saes,Saskia E.M. Schols,K Molitor,Mark van Geffen,K. Verbeek-Knobbe,Sweta Gupta,Brandon M. Hardesty,Amy D. Shapiro,Waander L. van Heerde	2019	11
12	Hemorrhagic disorders of fibrinolysis: a clinical review Journal of Thrombosis and Haemostasis ·Joline L. Saes,Saskia E.M. Schols,Waander L. van Heerde,Marten R. Nijziel	2018	53
13	Clinically relevant differences between assays for von Willebrand factor activity Journal of Thrombosis and Haemostasis ·Johan Boender,Jeroen Eikenboom,Johanna G. van der Bom,Karina Meijer,Joke de Meris,Karin Fijnvandraat,Marjon H. Cnossen,Britta A. P. Laros‐van Gorkom,Waander L. van Heerde,Evelien P. Mauser‐Bunschoten,Moniek P.M. de Maat,Frank W.G. Leebeek	2018	37
14	Platelet-Rich Plasma Can Replace Fetal Bovine Serum in Human Meniscus Cell Cultures Tissue Engineering Part C Methods ·Veronica K. Gonzales,Eric L.W. de Mulder,Trix de Boer,Gerjon Hannink,Tony G. van Tienen,Waander L. van Heerde,Pieter Buma	2013	25
15	Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients Thrombosis Research ·Mark van Geffen,Natascha C.J. Mathijssen,Pål André Holme,Britta A. P. Laros‐van Gorkom,Marian G.J. van Kraaij,Rosalinde Masereeuw,Flora Peyvandi,Waander L. van Heerde	2013	9
16	Improvements in Factor VIII Inhibitor Detection: From Bethesda to Nijmegen Seminars in Thrombosis and Hemostasis ·Bert Verbruggen,Waander L. van Heerde,Britta Laros‐van Gorkom	2009	49
17	Salivary biomarkers associated with perceived satiety and body mass in humans PROTEOMICS - CLINICAL APPLICATIONS ·Lucien F. Harthoorn,Raymond G. Schipper,Arnoud Loof,P. Vereijken,Waander L. van Heerde,Eric Dransfield	2007	14
18	Antithrombotic action of annexin V proved as efficient as direct inhibition of tissue factor or thrombin European Journal of Clinical Investigation ·Ana M. Galán,Waander L. van Heerde,Ginés Escolar,Antonio Ordinas,J J Sixma,Philip G. de Groot	2006	16
19	Prophylactic use of rFVIIa in congenital factor VII deficiency: mechanism of action Haematologica ·Waander L. van Heerde	2004	1
20	The presence of antiphospholipid antibodies is not related to increased levels of annexin A5 in plasma Journal of Thrombosis and Haemostasis ·Waander L. van Heerde,Chris Reutelingsperger,Cecile Maassen,Petra Lux,R. H. W. M. Derksen,Philip G. de Groot	2003	11

About Waander L. van Heerde

Waander L. van Heerde is a scholar working on Hematology, Genetics and Internal Medicine, having authored 102 papers that have together received 3.6k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (38 papers), Platelet Disorders and Treatments (33 papers), Blood Coagulation and Thrombosis Mechanisms (28 papers), S100 Proteins and Annexins (18 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers), Cell death mechanisms and regulation (8 papers), Blood properties and coagulation (6 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (374 citations) and Internal Medicine (103 citations). Waander L. van Heerde has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Chris Reutelingsperger, Philip G. de Groot, Arnoud Loof, Britta A. P. Laros‐van Gorkom, Mark van Geffen, Ebo DeMuinck, Pieter A. Doevendans, Leo Hofstra, Saskia E.M. Schols and Stefan M. van den Eijnde. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact